QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model
Jessica Kalra(University of British Columbia), Marcel B. Bally(BC Cancer Agency)
Cited by 73
Related Papers
Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer
|PLoS ONE|2013|101
Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent
|International Journal of Nanomedicine|2017|65
Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1
|Oncogene|2010|49